Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.46 USD | +0.81% | +30.46% | +32.71% |
05-08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
05-08 | Myriad Genetics Shares Rise After Reporting Narrower Q1 Adjusted Loss, Higher Revenue | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.71% | 2.29B | |
-1.29% | 12.64B | |
-0.47% | 8.37B | |
+5.68% | 5.37B | |
+22.87% | 5.26B | |
-2.03% | 4.58B | |
-53.48% | 3.16B | |
+19.30% | 2.89B | |
-8.42% | 2.22B | |
-3.55% | 1.91B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Myriad Genetics Names George Daneker Jr. as President, Chief Clinical Officer of Oncology